drugset / Trial / NCT04552990

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

NCT04552990 ↗

Phase 2 Completed 16 enrolled Memorial Sloan Kettering Cancer Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to find out whether injecting ALA into the skin with a jet-injection device and activating the drug with light is a safe treatment that causes few or mild side effects in people with basal cell carcinoma.

Timeline

Start
2020-09-09
Primary completion
2025-04-04
Completion
2025-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Levulan Kerastick Unknown 0.08 ml Other
Subject Levulan Kerastick Unknown 20 % Other